{"id":"W3110243001","doi":"10.1016/j.annder.2020.09.558","title":"Efficacité et tolérance du bimékizumab chez des patients présentant un psoriasis en plaques modéré à sévère : résultats de BE VIVID, une étude de phase 3 de 52 semaines, randomisée, en double aveugle, contrôlée versus ustékinumab et versus placebo","year":2020,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Medicine; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002142361,0.001548959,0.002102607,0.0003173059,0.0007127802,0.000207571,0.001500876,0.002369948,0.0002522649],"category_scores_gemma":[0.004737877,0.001536355,0.0008464769,0.0008182696,0.001137651,0.0006317268,0.000610483,0.001554901,0.0002387743],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001393616,"about_ca_system_score_gemma":0.002258983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008094248,"about_ca_topic_score_gemma":0.001443843,"domain_scores_codex":[0.9869669,0.006651533,0.001377205,0.001508685,0.0002765708,0.003219102],"domain_scores_gemma":[0.9881917,0.009281428,0.0007455256,0.0008281944,0.0003536622,0.0005994607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5527708,0.01151507,0.1449916,0.001881588,0.01901835,0.01546132,0.09567685,0.008602338,0.02610488,0.005868469,0.05198716,0.06612164],"study_design_scores_gemma":[0.5631566,0.007374615,0.05043321,0.0009455216,0.00663776,0.003666637,0.008452218,0.002980194,0.2916429,0.002002554,0.05822149,0.004486359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9450468,0.01902409,0.002886634,0.02583203,0.002214539,0.001804654,0.001518065,0.0007752339,0.0008979258],"genre_scores_gemma":[0.9511318,0.03705897,0.004069685,0.00514631,0.0002907571,0.0006227145,0.001316596,0.0001742117,0.0001890205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.265538,"threshold_uncertainty_score":0.9997259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04669831386881731,"score_gpt":0.3184699074482137,"score_spread":0.2717715935793964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}